The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 08, 2021
Filed:
Dec. 29, 2016
Applicant:
Kyoto University, Kyoto, JP;
Inventors:
Haruhisa Inoue, Kyoto, JP;
Takayuki Kondo, Kyoto, JP;
Assignee:
KYOTO UNIVERSITY, Kyoto, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); A61K 45/06 (2006.01); A61K 31/352 (2006.01); A61K 31/353 (2006.01); A61P 25/28 (2006.01); A61K 31/357 (2006.01); A61K 31/405 (2006.01); A61K 31/4709 (2006.01); A61K 31/404 (2006.01); A61K 31/10 (2006.01); A61K 31/48 (2006.01); A61K 31/7048 (2006.01); A61K 31/095 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4985 (2013.01); A61K 31/095 (2013.01); A61K 31/10 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/357 (2013.01); A61K 31/404 (2013.01); A61K 31/405 (2013.01); A61K 31/4709 (2013.01); A61K 31/48 (2013.01); A61K 31/7048 (2013.01); A61K 45/06 (2013.01); A61P 25/28 (2018.01);
Abstract
The present invention provides a prophylactic or therapeutic agent for Alzheimer's disease (AD) containing a combination of two or more compounds selected from the group consisting of compounds shown by compound Nos. 1 to 130. Since these compounds are existing drugs that have already been confirmed actually for safety and pharmacokinetics in human, they can be a means for a pre-emptive treatment of people at risk of AD and in a stage before developing mild cognitive impairment (MCI).